Major Players - Inhalation Anaesthesia Industry

Apr, 2023 - by CMI

Major Players - Inhalation Anaesthesia Industry

 

An Inhalation anaesthetic is a chemical compound possessing general anaesthetic properties that can be delivered via inhalation. Inhalation anaesthetics are widely used for the induction and maintenance of general anesthesia during surgery. Isoflurane is the most potent of the volatile anaesthetics in clinical use.

As of 2021, the global Inhalation Anaesthetic Market was valued at U.S$ 1,223.08 Million and is forecast to reach a value of U.S$ 1,636.72 Million by 2028 at a CAGR of 4.3% between 2022 and 2028.

Top Companies in the Inhalation Anaesthesia Industry:

1) Baxter International Inc.

Baxter International Inc. is an American multinational healthcare company that focuses on products to treat kidney disease, and other chronic and acute medical conditions. The products manufactured include Medical supplies to treat haemophilia and kidney disease and provide intravenous therapy. The company was founded in the year 1931, and the headquarters are located in Deerfield, Illinois, U.S. the company was founded by Donald Baxter.

In September 2021, Baxter announced its plans to acquire Hill-rom for U.S$ 12.4 Billion. The acquisition was completed in December 2021, for U.S$ 12.5 Billion.

2) Merck KGaA

Merck Group, commonly known as Merck is a German multinational science and technology company that manufactures products like Liquid crystals, life science and performance chemicals, Bioprocessing-Solutions and biopharmaceuticals. The company was founded in the year 1668, and the headquarters are located in Darmstadt, Germany. The company was founded by Friedrich Jacob Merck.

In December 2021, Merck completed the acquisition of Chord Therapeutics, a Swiss-based biotech company.

3) Hikma Pharmaceuticals

Hikma Pharmaceuticals Plc. Is a multinational pharmaceutical company that was the first Arab company to export pharmaceutical products in the U.S. The Company was founded in the year 1978 by Samih Darwazah. The Headquarters are located in London, England, UK. Products manufactured include Amoclan, Prograf, and Suprax. In January 2023, The company launched Naloxone Hydrochloride Injection,, in prefilled syringe form, which is used for the emergency treatment of opioid overdose.

In January 2023, The Company launched Naloxone Hydrochloride Injection, in prefilled syringe form, which is used for the emergency treatment of opioid overdose.

4) Dechra Pharmaceuticals plc.

Dechra Pharmaceuticals Plc. is a company that develops and markets veterinary products. The company is listed in the London Stock Exchange and is a constituent of the FTSE 250 Index. Dechra was founded in the year 1997, and the headquarters are located in Northwich, England, U.K. It mainly sells pharmaceuticals for dogs, cats, equine and food producing animals.

5) Jiangsu Hengrui Medicine

Jingsui Hengrui Pharmaceuticals Company ltd also known as Jiangsu Hengrui is a Chinese pharmaceutical company that manufactures and distributed various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication etc. It is the largest listed pharmaceutical company in China. The company was founded in 1990, and the headquarters are located in Lianyungang, Jiangsu, China

 

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.